The adequacy of current diagnostic criteria for making a diagnosis of ABPA ABPA tanısında güncel tanısal kriterler yeterli midir?


Creative Commons License

Nazik Bahçecioğlu S., Türk M., PAÇACI ÇETİN G., YILMAZ İ.

Tuberkuloz ve Toraks, vol.70, no.2, pp.141-148, 2022 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 70 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.5578/tt.20229804
  • Journal Name: Tuberkuloz ve Toraks
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.141-148
  • Keywords: ABPA, ABPA diagnostic criteria, ISHAM, Rosenberg, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, CHRONIC PULMONARY ASPERGILLOSIS, ANTIGENS, CLASSIFICATION, SENSITIZATION, FUMIGATUS, ASSAYS
  • Kayseri University Affiliated: No

Abstract

© 2022 by Tuberculosis and Thorax.The adequacy of current diagnostic criteria for making a diagnosis of ABPA Introduction: Currently, there are four different diagnostic criteria systems for allergic bronchopulmonary aspergillosis (ABPA): The Rosenberg-Patterson, Seropositive ABPA (ABPA-S), Central Bronchiectasis and ABPA (ABPA-CB), and the International Society for Human and Animal Mycology (ISHAM) ABPA study group criteria. This study aims to retrospectively compare these four diagnostic criteria in ABPA patients. Materials and Methods: Patients who were followed up with the diagnosis of ABPA were retrospectively re-evaluated using these four diagnostic criteria, and the superiority of these criteria to each other was determined. Results: A total of 10 ABPA patients were included in the study. Seven patients were diagnosed according to ISHAM ABPA study group diagnostic criteria and six patients according to the Rosenberg-Patterson diagnostic criteria. None of the patients fulfilled the criteria when evaluated individually with ABPA-S and ABPA-CB. Of patients diagnosed by ISHAM, five had a total IgE level above 1000 IU/mL and two had below 1000 IU/mL. Conclusion: We demonstrated that the diagnostic criteria developed by the ISHAM ABPA study group were superior to the others in diagnosing ABPA in cases with a total IgE level above 1000 IU/mL. However, all these criteria seem to be sufficient to diagnose ABPA in patients with a total IgE below 1000 IU/mL. We believe the necessity to demonstrate presence of Aspergillus fumigatus precipitating antibodies or specific IgG positivity should be questi-oned particularly in patients with radiologic findings compatible with ABPA and a total IgE level below 1000 IU/mL.